Scribe Therapeutics Inc. (SCTX) Live Share Price, Invest From India

Scribe Therapeutics Inc. Stock Performance

as on October 21, 2026 at 6:59 am IST

Day's Low
Day's High
$19.33
Day's Price Range
$21.37
$19.97
3.20%
Downside
7.01%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$19.97
100.00%
Downside
-100.00%
Upside

Scribe Therapeutics Inc. share price movements today

Previous Close: $19.39
Open: $19.60
Volume: 466.3K
Market Cap: $380.1M
Day's Low - High: $19.33 - $21.37

Scribe Therapeutics Inc. Historical Returns

1 Month Return: -41.24 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Scribe Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Scribe Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$380.1M

EPS (TTM)

-5.59

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

0.00

EBITDA

-27.8M

Revenue (TTM)

33.3M

Profit Margin

-97.00%

Return On Equity TTM

0.00%

Scribe Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Scribe Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Scribe Therapeutics Inc.	StrongBuy	$380.1M	NA	NA	-97.00%	0.00%
Moderna	Neutral	$87.0B	-31.87%	-27.32	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$126.7B	170.61%	28.85	86.04%	0.00%
Regeneron	Buy	$81.4B	38.98%	18.88	84.86%	0.47%

Analyst Recommendation on Scribe Therapeutics Inc. Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Scribe Therapeutics Inc.. Average target price of $51.75

Scribe Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Scribe Therapeutics Inc..

Current Price

$19.97

Analyzed by

4 Analysts

High

$60

Low

$37

Scribe Therapeutics Inc. target price $0, a slight upside of 0% compared to current price of $19.97. According to 4 analysts rating.

Indian Investors' Interest in Scribe Therapeutics Inc. Stock

Search interest for Scribe Therapeutics Inc. Stock has increased by 13% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 21, 2026 to October 21, 2026

Change:13% versus previous 30 day period

Scribe Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2025	Jun 2025	Mar 2026	Jun 2026
Total Revenue	17	4	2	1
Gross Profit	-	-	-	-
Operating Income	-5	-11	-12	-9
EBITDA	-2	-9	-15	-5
Interest Expense	0	0	0	0
Depreciation	0	0	0	0
Income Before Tax	-3	-10	-17	-6
Income Tax Expense	-	-	-	-
Net Income	-3	-9	-17	-6
Net Profit Margin	-20.00%	-202.18%	-776.85%	-337.70%

Scribe Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2024	Dec 2025
Total Revenue	27	51
Gross Profit	-	-
Operating Income	-42	-26
EBITDA	-32	-18
Interest Expense	2	2
Depreciation	2	3
Income Before Tax	-37	-23
Income Tax Expense	-	-
Net Income	-47	-21
Net Profit Margin	-174.32%	-42.62%

Scribe Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2025	Mar 2026	Jun 2026
Net Income	-9	-17	-6
Operating Cash Flow	-6	-7	-5
Investing Cash Flow	-	-	-
Financing Cash Flow	0	0	-1
Change in Cash	-3	7	15

Scribe Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2025
Net Income	-21
Operating Cash Flow	-45
Investing Cash Flow	-
Financing Cash Flow	0
Change in Cash	0

Global Institutional Holdings in Scribe Therapeutics Inc.

Check out the Institutions with significant holdings in Scribe Therapeutics Inc..

Funds	Holdings
ARK	9.45%
Vanguard	2.44%
iShares	2.00%
SPDR	0.13%
Bridgeway	0.04%

See all

Insights on Scribe Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 1 month, SCTX stock has moved down by -41.2%

About Scribe Therapeutics Inc.

Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines. The company engineers proprietary technologies to target the genetic drivers of disease, with an initial focus on atherosclerotic cardiovascular disease (ASCVD), aiming to shift treatment from chronic care to preventative intervention.

Organisation	Scribe Therapeutics Inc.
Headquarters	1150 MARINA VILLAGE PARKWAY, Alameda, CA, 94501, US
Industry	Biotechnology
CEO	Benjamin L. Oakes

Key Management of Scribe Therapeutics Inc.

Name	Title
Dr. Svetlana Lucas Ph.D.	Chief Operating Officer
Mr. David F. Savage Ph.D.	Co-Founder & Scientific Advisor
Mr. Sunny Mok M.B.A., Ph.D.	Senior Vice President of Operations
Stephen V. Thau	Secretary
Ms. Chitra Sharma M.S.	Senior Vice President of Development
Dr. Benjamin L. Oakes Ph.D.	Co-Founder, President, CEO & Chairman
Mr. David L. Parrot M.B.A.	CFO & Treasurer
Dr. Jennifer A. Doudna Ph.D.	Co-Founder & Scientific Advisor
Mr. Brett T. Staahl Ph.D.	Co-Founder & VP of External Innovation
Mr. Richard Hector J.D., Ph.D.	Head of Intellectual Property

FAQs

What is Scribe Therapeutics Inc. share price today?

Scribe Therapeutics Inc. share price today is $19.97 as on October 21, 2026 at 1:29 am IST at the close of the market. Scribe Therapeutics Inc. share today touched a day high of $21.37 and a low of $19.33.

What is the 52 week high and 52 week low for Scribe Therapeutics Inc. share?

Scribe Therapeutics Inc. share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Scribe Therapeutics Inc. stock price today i.e. October 21, 2026 at 1:29 am IST is closed at $19.97,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Scribe Therapeutics Inc.'s market capitalisation today?

Scribe Therapeutics Inc. market capitalisation is $0.00T as on October 21, 2026 at 1:29 am IST.

How to invest in Scribe Therapeutics Inc. Stock (SCTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Scribe Therapeutics Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Scribe Therapeutics Inc. Stock (SCTX) from India?

Indian investors can start investing in Scribe Therapeutics Inc. (SCTX) shares with as little as ₹94.93000030517578 or $1 (as of October 21, 2026 at 5:46 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.30 in Scribe Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on October 21, 2026 at 5:46 am IST). Based on Scribe Therapeutics Inc. share’s latest price of $19.97 as on October 21, 2026 at 1:29 am IST, you will get 0.5008 shares of Scribe Therapeutics Inc.. Learn more about fractional shares .